CC BY 4.0 · Journal of Health and Allied Sciences NU 2024; 14(03): 420-425
DOI: 10.1055/s-0043-1772707
Brief Report

Prophage and Plasmid-Mediated Beta-Lactamases in Multidrug-Resistant Extraintestinal Escherichia coli

1   Division of Infectious Diseases, Nitte University Center for Science Education and Research, Mangaluru, Karnataka, India
,
Akshatha Dinesh
2   Nitte University Center for Science Education and Research, Mangaluru, Karnataka, India
,
Rajeshwari Vittal
3   Division of Environmental Health and Toxicology, Nitte University Center for Science Education and Research, Mangaluru, Karnataka, India
,
4   Department of Microbiology, Madras Medical Mission, Chennai, Tamil Nadu, India
› Author Affiliations

Abstract

Objectives Antibiotic resistance can arise as a mutation to adapt to stress or be mediated by horizontal gene transfer. This study aimed at identifying the resistance determinants present in the mobile genetic elements of prophages and plasmids within multidrug-resistant (MDR) extraintestinal Escherichia coli.

Materials and Methods Thirty-five anonymized MDR E. coli isolates of nonintestinal infections were confirmed for their antimicrobial resistance to six categories of antimicrobials by the disk diffusion test. Genes coding for beta-lactamases and carbapenemases in bacterial genome, plasmid, and prophage fractions were separately determined by polymerase chain reaction. Transducing ability of prophages carrying resistance genes was determined.

Results Twenty-six isolates were positive for the gene bla CTX-M, nine for bla TEM, one each for bla KPC and bla VIM, thirteen for bla NDM, and seven for bla OXA. A majority of these isolates carried these determinants in plasmids and prophage fractions. Twenty-one percent of the prophage fractions (4 of 19) were able to successfully transfer resistance to sensitive isolates.

Conclusion This study indicates bla CTX-M, bla TEM, and bla NDM genes that are reported most frequently in MDR isolates are more frequent in the plasmid and prophage fractions thus supporting for increased mobility.

Approvals Statement

The study was approved by the Institutional Research Advisory Committee via order INST/RAC/2017-18/9 and the Institutional Ethics Committee via sanction order INST.EC/2017-18/001 dated 22.01.2018.


Supplementary Material



Publication History

Article published online:
24 August 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Tacconelli E, Carrara E, Savoldi A. et al; WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018; 18 (03) 318-327
  • 2 The Center for Disease Dynamics. Economics & Policy. Resistance Map Antibiotic Resistance. 2021 Accessed August 08, 2023 at: https://resistancemap.cddep.org/AntibioticResistance.php
  • 3 Smyth C, Leigh RJ, Delaney S, Murphy RA, Walsh F. Shooting hoops: globetrotting plasmids spreading more than just antimicrobial resistance genes across One Health. Microb Genom 2022; 8 (08) mgen000858
  • 4 Rozwandowicz M, Brouwer MSM, Fischer J. et al. Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J Antimicrob Chemother 2018; 73 (05) 1121-1137
  • 5 Brabban AD, Hite E, Callaway TR. Evolution of foodborne pathogens via temperate bacteriophage-mediated gene transfer. Foodborne Pathog Dis 2005; 2 (04) 287-303
  • 6 Kondo K, Kawano M, Sugai M. Distribution of antimicrobial resistance and virulence genes within the prophage-associated regions in nosocomial pathogens. MSphere 2021; 6 (04) e0045221
  • 7 CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute 2019
  • 8 Su MT, Venkatesh TV, Bodmer R. Large- and small-scale preparation of bacteriophage λ lysate and DNA. Biotechniques 1998; 25 (01) 44-46
  • 9 Woods WH, Egan JB. Prophage induction of noninducible coliphage 186. J Virol 1974; 14 (06) 1349-1356
  • 10 Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection. JAC Antimicrob Resist 2021; 3 (03) dlab092
  • 11 Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother 2017; 72 (08) 2145-2155
  • 12 Jaggi N, Chatterjee N, Singh V. et al. Carbapenem resistance in Escherichia coli and Klebsiella pneumoniae among Indian and international patients in North India. Acta Microbiol Immunol Hung 2019; 66 (03) 367-376
  • 13 Suzuki Y, Sato T, Fukushima Y. et al. Contribution of β-lactamase and efflux pump overproduction to tazobactam-piperacillin resistance in clinical isolates of Escherichia coli. Int J Antimicrob Agents 2020; 55 (04) 105919
  • 14 Balcazar JL. Bacteriophages as vehicles for antibiotic resistance genes in the environment. PLoS Pathog 2014; 10 (07) e1004219
  • 15 Muniesa M, García A, Miró E. et al. Bacteriophages and diffusion of β-lactamase genes. Emerg Infect Dis 2004; 10 (06) 1134-1137
  • 16 Mohan Raj JR, Vittal R, Huilgol P, Bhat U, Karunasagar I. T4-like Escherichia coli phages from the environment carry blaCTX-M . Lett Appl Microbiol 2018; 67 (01) 9-14
  • 17 Galetti R, Andrade LN, Varani AM, Darini ALC. A phage-like plasmid carrying blaKPC-2 gene in carbapenem-resistant Pseudomonas aeruginosa. Front Microbiol 2019; 10: 572
  • 18 Pfeifer E, Bonnin RA, Rocha EPC. Phage-Plasmids spread antibiotic resistance genes through infection and lysogenic conversion. MBio 2022; 13 (05) e0185122
  • 19 Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K. Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989; 33 (09) 1451-1456
  • 20 McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999; 12 (01) 147-179
  • 21 Batchelor M, Hopkins K, Threlfall EJ. et al. bla(CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother 2005; 49 (04) 1319-1322
  • 22 Mahrouki S, Ben-Achour N, Chouchani C, Ben-Moussa M, Belhadj O. Identification of plasmid-encoded extended spectrum beta-lactamases produced by a clinical strain of Proteus mirabilis. Pathol Biol (Paris) 2009; 57 (04) e55-e59
  • 23 Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997–1998. J Antimicrob Chemother 2000; 45 (02) 183-189
  • 24 Yigit H, Queenan AM, Anderson GJ. et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumonia . Antimicrob Agents Chemother 2001; 45 (04) 1151-1161
  • 25 Shenoy KA, Jyothi EK, Ravikumar R. Phenotypic identification & molecular detection of bla (ndm-1) gene in multidrug resistant Gram-negative bacilli in a tertiary care centre. Indian J Med Res 2014; 139 (04) 625-631
  • 26 Fallah F, Borhan RS, Hashemi A. Detection of bla(IMP) and bla(VIM) metallo-β-lactamases genes among Pseudomonas aeruginosa strains. Int J Burns Trauma 2013; 3 (02) 122-124
  • 27 Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011; 70: 119-125